Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance Article (Faculty180)

cited authors

  • Kuang, Ye-Hong; Shen, Tong; Chen, Xiang; Sodani, Kamlesh; Hopper-Borge, Elizabeth; Tiwari, Amit K; Lee, Jeferson WKK; Fu, Li-Wu; Chen, Zhe-Sheng

publication date

  • 2010

published in

start page

  • 154

volume

  • 79